Abstract Search

ea0073aep305 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Comparing impact of SGLT2 inhibitors and GLP-1 agonists on lipid profile among the patients with diabetes mellitus Type 2. Results of a prospective 18-week observational study

Bostoganashvili Nestan , Kvanchakhadze Rusudan , Mikadze Ketevan , Panchulidze Manoni

BackgroundIn Georgia, significantly huge number of patients with Diabetes Mellitus Type 2 (DMT2) suffer from cardiovascular diseases (CVD) and obesity. Since, dyslipidemia is one of major factors, leading to cardiovascular (CV) mortality, it is crucial to investigate the effects of relatively novel hypoglycemic agents- Sodium Glucose Cotransporter 2 (SGLT2) inhibitors (Dapagliflozin) or Glucagon like peptide 1 (GLP-1) agonists (Liraglutide) on lipid prof...

2 shares

Endocrine Abstracts

Comparing impact of SGLT2 inhibitors and GLP-1 agonists on lipid profile among the patients with diabetes mellitus Type 2. Results of a prospective 18-week observational study

BiosciAbstracts